Coherus BioSciences, Inc. (NASDAQ:CHRS) Q4 2023 Earnings Call Transcript
Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.62 EPS, expectations were $-0.21.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | 29,647,000 | $19,355,044 | -7% | 0.78% | |
2. | Millennium Management Israel Englander | 2,842,319 | $9,464,922 | +1212% | 0% |
3. | Citadel Investment Group Ken Griffin | 1,987,897 | $6,619,697 | -26% | 0% |
4. | 10,306,000 | $5,845,489 | 0.08% | ||
5. | 10,000,000 | $5,673,843 | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$13.42 | 3,700 | Officer | 35,118 | 2021-06-09 | Filing | |
$13.50 | 425,926 | Director | 2,557,759 | 2014-11-12 | Filing | |
$13.50 | 164,963 | Other | 3,042,019 | 2014-11-12 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$2.02 | 223,100 | 731,693 | 2023-11-22 | Filing | ||
$16.80 | 3,507 | Officer | 31,611 | 2021-10-15 | Filing | |
$16.12 | 286,076 | Director | 0 | 2021-09-29 | Filing | |
$17.17 | 48,329 | Director | 286,076 | 2021-09-28 | Filing | |
$18.06 | 100,150 | Director | 334,405 | 2021-09-27 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 12,074,695 | $40,208,736 | 0% | |
2. | 10,357,412 | $34,490,182 | 0% | |
3. | 7,381,116 | $24,579,116 | 0.13% | |
4. | 30,000,000 | $16,582,170 | 0% | |
5. | 25,698,000 | $14,575,722 | 0.04% |